{
    "2018-04-03": [
        [
            {
                "time": "",
                "original_text": "震荡之中不断加仓这路聪明资金是这么布局的",
                "features": {
                    "keywords": [
                        "震荡",
                        "加仓",
                        "聪明资金"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "药明康德闪电过会 三年十倍的私有化奇迹",
                "features": {
                    "keywords": [
                        "药明康德",
                        "过会",
                        "私有化",
                        "奇迹"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "东吴医药行业周观点：药明康德成为第二家“IPO快速通道”的独角兽公司 创新药主题迎来新一轮投资机会",
                "features": {
                    "keywords": [
                        "药明康德",
                        "IPO快速通道",
                        "创新药",
                        "投资机会"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[买入评级]医药生物行业深度分析报告：医保放量：2018年又一确定性机会",
                "features": {
                    "keywords": [
                        "买入评级",
                        "医药生物",
                        "医保放量",
                        "确定性机会"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业卓越推：暂不推荐",
                "features": {
                    "keywords": [
                        "医药行业",
                        "暂不推荐"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "仁东医学：精准检测为肿瘤免疫治疗保驾护航",
                "features": {
                    "keywords": [
                        "仁东医学",
                        "精准检测",
                        "肿瘤免疫治疗"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "[增持评级]医药生物行业月报：行业发展持续向好 布局有增速、有未来的公司",
                "features": {
                    "keywords": [
                        "增持评级",
                        "医药生物",
                        "行业向好",
                        "布局未来"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[看好评级]2017年度药品审评报告分析(医药生物行业)：上市品种大幅增加 创新药申报激增",
                "features": {
                    "keywords": [
                        "看好评级",
                        "药品审评",
                        "创新药",
                        "申报激增"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[强于大市评级]医药行业周报：医药指数持续创新高 把握医药结构化牛市",
                "features": {
                    "keywords": [
                        "强于大市评级",
                        "医药指数",
                        "创新高",
                        "结构化牛市"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[强于大市评级]医药生物行业投资策略：从工业数据窥见医药行业配置意义与投资价值",
                "features": {
                    "keywords": [
                        "强于大市评级",
                        "医药生物",
                        "工业数据",
                        "投资价值"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}